COMP <GO>
CW vs LRCX // RETURN ON INVESTED CAPITAL (ROIC)
Curtiss-Wright Corporation (NYSE) VS. Lam Research Corporation (NASDAQ) • 15-METRIC TALLY: CW 6
— LRCX 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LRCX
LAST: $476.01 (-4.17%) • MKT CAP: $18.35B
roic
17.10%
LAST: $239.11 (-6.01%) • MKT CAP: $317.78B
roic
25.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CW VS. LRCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CW | LRCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 37.20% | 50.50% | -13.30 | LRCX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 17.10% | 25.50% | -8.40 | LRCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.4x | 34.8x | -8.40 | CW | /valuation <GO> |
| Free Cash Flow Yield | 3.02% | 1.51% | +1.51 | CW | /fcf-yield <GO> |
| Operating Margin | 18.10% | 35.30% | -17.20 | LRCX | /operating-margins <GO> |
| Net Profit Margin | 13.80% | 31.30% | -17.50 | LRCX | /net-margins <GO> |
| Revenue Growth (YoY) | 12.10% | 26.00% | -13.90 | LRCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.19% | 0.40% | -0.21 | LRCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.46 | 21.80 | -15.34 | LRCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | CW | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.9 | 41.7 | +3.20 | CW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.30 | 1.29 | +0.01 | CW | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.8x | 36.7x | -4.90 | CW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.35B | $317.78B | -$299.43B | LRCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CW REV | LRCX REV | CW GROSS % | LRCX GROSS % | CW FCF | LRCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.50B | $23.23B | 37.2% | 50.5% | $553.7M | $4.81B |
| FY 2024 | $3.12B | $18.44B | 37.0% | 48.7% | $483.3M | $5.34B |
| FY 2023 | $2.85B | — | — | — | $320.0M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CW // BETA 1.30
LRCX // BETA 1.29